Geometry.Net - the online learning center
Home  - Health_Conditions - Lyells Syndrome
e99.com Bookstore
  
Images 
Newsgroups
Page 2     21-40 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Lyells Syndrome:     more detail
  1. Dermatose Bulleuse: Brûlure, Impétigo, Épidermolyse Bulleuse, Épidermolyse Bulleuse Dystrophique, Syndrome de Lyell, Dermite Des Prés (French Edition)

21. Lyell's Syndrome & Vaccination
Lyell s syndrome and vaccination. Briukhanova LK, et al. See Related Articles Lyell ssyndrome following vaccination with diphtheriapertussis-tetanus
http://www.whale.to/vaccines/lyell's.html
Lyell's syndrome and vaccination
Briukhanova LK, et al. [See Related Articles] [Lyell's syndrome following vaccination with diphtheria-pertussis-tetanus vaccine in a 9-month-old child]. Pediatriia. 1979 Feb;(2):60-1. Russian. No abstract available.PMID: 450585; UI: 79200814.

22. SKIN Disorders And Vaccines
Lyell s syndrome following vaccination with diphtheriapertussis-tetanus vaccinein a 9-month-old child. Pediatriia. 1979 Feb;(2)60-1. Russian.
http://www.whale.to/vaccines/skin.html
Skin Disorders and Vaccines Bullous pemphigoid
Dermatomyositis

Erythema multiforme

Erysipelas
... Scleroderma Salzburger Elternstudie (Survey of / by parents) (2001-2005) Results: Unvaccinated children virtually no asthma; vaccinated 1 in 10; and three to five times less Neurodermatis .......Englische Kohortenstudie (1988 - 1999) Results: Vaccinated children are up to 14 times more likely to have asthma than the unvaccinated and up to nine times more like to have skin problems [May 2005 Germany] Who is healthier, the vaccinated or the unvaccinated?! "Today, there are about 150 vaccines being worked on, and within the next decade, we could have a flu vaccine for the left nostril and one for one right nostril. Mankind will be used as a pin cushion. For every vaccination, minimal encephalopathy destroys brain cells. As a result, in Germany, there are 1.2 million children who have contracted hyperkinetic syndrome who are then treated with Psychopharmeca (a drug similar to Ritalin) used to calm them down... We have hundreds of thousands of so-called minimal cerebral dysfunction cases and millions of neurodermatitis patients. In Germany, there are millions of people with allergies. We don’t just produce minimal encephalopathies in the brain, but we also produce modifications of the genetic code."

23. USE OF CULTURED HOMOLOGOUS KERATINOCYTES IN THE LOCAL TREATMENT OF LVELUS SYNDRO
The modifications of the skin covering that occur in Lyell s syndrome requiregeneral and The purposes of the local treatment of Lyell s syndrome are
http://www.medbc.com/annals/review/vol_9/num_3/text/vol9n3p163.htm
Annals of Burns and Fire Disasters - vol. IX - n. 3 - September 1996 USE OF CULTURED HOMOLOGOUS KERATINOCYTES IN THE LOCAL TREATMENT OF LVELUS SYNDROME Napoli B., D'Arpa N., Masellis M., D'Amelio L., Genovese M. Divisione di Chirurgia Plastica e Terapia delle Ustioni, Ospedale Civico, Palermo, Italy SUMMARY. Introduction
Lyell's syndrome resembles a partial-thickness burn because of the presence of erythema and the formation of bullae, the surface of which consists of the epidermis, with subsequent detachment exposing the dermal layer of the cutis.
The modifications of the skin covering that occur in Lyell's syndrome require general and local treatment analogous to that required in burns. For this reason toxic epidermal necrolysis (as Lyell's syndrome is also known) is a pathology that is often treated in Burn Centres.
The purposes of the local treatment of Lyell's syndrome are:
  • to reduce the intensely painful burning feeling to prevent heat and fluid loss to prevent bacterial contamination and septic processes to prevent the lesions from becoming deeper to promote re-epithelialization
The methods of local treatment described in the literature (air-fluidized bed,2 hyperbaric oxygen therapy,' antibiotic and antiseptic treatment,'-' skin substitutes` 14) are not always sufficient to achieve these purposes. Barring complications, re-epithelialization generally occurs within two weeks (as in partial-thickness burns) and never in less than a week.

24. NON-THERMIC SKIN AFFECTIONS
Lyell s syndrome toxic epidermal necrolysis(TEN),. - staphylococcal scaldedskin syndrome (SSSS), - extensive necrotic affections such as purpura
http://www.medbc.com/meditline/review/acta/vol_42/num_4/text/vol42n4p111.asp
Acta, vol. 42 - 2000
NON-THERMIC SKIN AFFECTIONS
Broz L., Kripner J.
Burn Center, Charles University Hospital Krâlovské Vinohrady, Prague, Czech Republic
SUMMARY
ZUSAMMENFASSUNG
Die nicht-thermische Beschâdigungen der Hautdeckung Broe L., Kripner J.
Key words: non-thermie affection of the skin cover, Stevens-Johnson sy, Lyell sy, staphylococcal scalded skin syndrome, meningococcal sepsis
The similarity of some non-thermie affections of the skin cover with burn injuries from the aspect of general and local treatment is an indication for treatment at a burn department. This applies to the following conditions: - Stevens-Johnson's syndrome (SJS), - Lyell's syndrome - toxic epidermal necrolysis(TEN), - staphylococcal scalded skin syndrome (SSSS), - extensive necrotic affections such as purpura fulminans (PF).
Fig. 1 - Necrotic changes on the forearm and gangrene of distal phalanges of the right hand.
Fig. 2 - Condition after amputation of distal phalanges of the tnd - 5tn fingers of the right hand and after autotransplantation of the defect
Fig. 3a

25. Entrez PubMed
Novel treatments for druginduced toxic epidermal necrolysis (Lyell s syndrome).Paquet P, Pierard GE, Quatresooz P. Department of Dermatopathology
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1

26. Entrez PubMed
The mucous lesions are customary in toxic epidermal necrolysis. The acute ocularlesions have led to
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3

27. Media Statement - Lyell's And SJS
The drugs associated with Lyell s syndrome are sometimes sulphonamides, barbiturates,phenytoin, There were no specific reports for Lyell s syndrome.
http://www.ibuprofen-foundation.com/news/media/mediastatement-LyellsandSJS.htm

Home
Media Statement Newsletters Media Releases Conferences Photo Library
MEDIA STATEMENT 17th February 2005 Lyell's Syndrome and Stevens-Johnson Syndrome Erythema multiforme Erythema multiforme is a type of hypersensitivity reaction that occurs in response to medications, infections, or illness. Medications associated with erythema multiforme include sulfonamides, penicillins, barbiturates, and phenytoin. The exact cause is unknown. The disorder is believed to involve damage to the blood vessels of the skin with subsequent damage to skin tissues. Erythema multiforme may present with a classic skin lesions with or without systemic symptoms. Where the blistering and mucosal lesions are severe, the disease is termed Stevens-Johnson syndrome. This is usually associated with high fever and sometimes also anterior uveitis, pneumonia, renal failure, polyarthritis, or diarrhoea. Lyell's Syndrome (Toxic epidermal necrolysis) In the published literature, very little information is available on the subject of cutaneous adverse effects related to low dose, short-term use of ibuprofen. However, a literature search found 3 case reports of Stevens-Johnson Syndrome in which ibuprofen was implicated (Sternlieb and Robinson 1978; Srivastava et al. 1998, Taghian M 2004).

28. Blackwell Synergy - Cookie Absent
Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87cases of toxic epidermal necrolysis (Lyell s syndrome).
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1399-6576.2005.00685.x
 Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.

29. Blackwell Synergy - Cookie Absent
Cystic lesion of the parotid following druginduced toxic epidermal necrolysis (Lyell ssyndrome) Lyell s syndrome. parotid. toxic epidermal necrolysis
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-0714.2005.00315.x
 Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.

30. DermIS / Main Menu / PeDOIA / Table Of Contents / 6 Non-Eczematous Allergic E
information on the diagnosis DrugInduced Lyell s syndrome If you are apatient with Drug-Induced Lyell s syndrome , please complete our
http://dermis.multimedica.de/doia/diagnose.asp?zugr=p&lang=e&diagnr=149&topic=i

31. Erythema Multiforme
erythema multiforma; febrile mucocutaneous syndrome; Lyell s syndrome; StevensJohnsonsyndrome; toxic epidermal necrolysis
http://www.icongrouponline.com/health/Erythema_Multiforme_Ph.html
ICON Health Publications
Official Health Sourcebooks Search ICON Health Titles: ERYTHEMA MULTIFORME
A Bibliography, Medical Dictionary,
and
Annotated Research Guide to Internet References

(erythema multiforma; febrile mucocutaneous syndrome; Lyell's syndrome; Stevens-Johnson syndrome; toxic epidermal necrolysis) P A P E R B A C K Paperback Book Paperback Book Order by phone: 800-843-2665 (within USA) 1-201-272-3651 (from outside USA) Paperback Book Shipped in 3 to 5 business days
E B O O K Electronic File * E-Book version sent via e-mail in 2 business days Pages Price $34.95(USD) ISBN Published Synopsis In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with erythema multiforme is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so. Related Conditions/Synonyms erythema multiforma; febrile mucocutaneous syndrome; Lyell's syndrome; Stevens-Johnson syndrome; toxic epidermal necrolysis

32. Aids-hospice-mouroir-sida-medical-protocol-allergy-en
Lyell s syndrome (or Bullous epidermolyse/exfolliative dermatitis or toxicepidermal necrolysis ). // pxx008 // pxx118 // pxx165.
http://www.stylite.net/sida-aids/protocol06-allergy-en.htm
Welcome page Diagnosis/photos Back former position Thumbnails ... General table
6- Allergic Reaction
Allergy and HIV
It is possible with HIV patients to have an allergic reaction to a drug that was taken in the past without causing any problems. (Especially Bactrim If no alternative curative drugs are available, we sometimes have to accept mild allergic reactions or other side effects of drugs. Continue to give the curative drugs that cause the allergy and add mild symptomatic drugs ( calamine, chlorpheniramine, betamethasone cream, prednisolone Reactions such as mild eczema ), jaundice ( ) or pruritus are sometimes "a lesser evil"… BUT we certainly should not continue any treatment that is causing Stevens Johnson/erythema multiforme ...) (see " 32-Unable to eat " & " 17-herpes ") "Lyell's syndrome" ...) (See " 30-Lyell "), acute urticaria + bronchospasm or severe generalized erythroderma ) (See "

33. EUBS4
As efficient defence therapy in Lyell s syndrome, in these last few years HBO has HBO treatment in Lyell s syndrome tends to promote the detachment of
http://mbox.unipa.it/~ccare/hbo/eubs4.htm
HYPERBARIC OXYGEN TREATMENT (HBO) IN TOXIC EPIDERMAL NECROLYSIS (TEN)
B. Sparacia, A. Sansone
Toxic Epidermal Necrolysis is a form of cutaneomucous reaction characterized by fever, systemic toxicity, erythema, bullae followed by an extended exfoliation. Such a syndrome was described in 1956 by Lyell who outlined its clinical picture.
Etiologically many factors have been indicated as etiological moments of TEN: drugs, microorganisms, food and other elements having an antigenic action. Some drugs may act as factors causing TEN; among them there are Fans, Antibiotics, Anticonvulsants (Phenobarbital, Carbomazefine) and Allopurinol.
Some factors such as connective diseases or infections (29), may make it easier for TEN to arise. TEN has been also associated with morbilli, flu, vaccination, serious infections, septicemia by Clostridium Septicum, Escherichia Coli, Klebsiella Pneumoniae, Pseudomonas Aeruginosa, Streptococcus Pyogenes (7).That is the reason why during TEN pathogenesis a great number of physiopathological events occur; these events are not quite clear and various mechanisms have been hypothesized, such as:
a) reaction by delayed hypersensitivity type IV
b) keratinocytic cytotoxicity mediated by a lymphocytic substance
c) reaction by cytotoxicity type II
d) non immunologically mediated necrolysis.

34. Arch Dermatol -- Abstract: The Culprit Drugs In 87 Cases Of Toxic Epidermal Necr
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell s syndrome) Toxic Epidermal Necrolysis and StevensJohnson syndrome Does Early
http://archderm.ama-assn.org/cgi/content/abstract/123/9/1166
Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress
Vol. 123 No. 9, September 1987 Featured Link E-mail Alerts ARTICLE Article Options Send to a Friend Readers Reply Submit a reply Similar articles in this journal Literature Track Add to File Drawer Download to Citation Manager PubMed citation Articles in PubMed by Guillaume JC Touraine R Articles that cite this article Contact me when this article is cited
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome)
J. C. Guillaume, J. C. Roujeau, J. Revuz, D. Penso and R. Touraine
Between 1972 and 1985, 87 patients with toxic epidermal necrolysis (TEN) were admitted to the dermatological intensive care unit at Hopital Henri Mondor, Creteil, France. The culpable drug was determined by standardized criteria. Only three patients had received no drugs before the onset of TEN. Most patients (71 of 87) were receiving more than one drug. Patients

35. Arch Dermatol -- Table Of Contents (Vol. 123 No. 9, September 1987)
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell s syndrome)JC Guillaume; JC Roujeau; J. Revuz; D. Penso; R. Touraine Arch Dermatol.
http://archderm.ama-assn.org/content/vol123/issue9/index.dtl
Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress
Vol. 123 No. 9, pp. 1119-1227, September 1987 Content Access Sign in/out Activate online subscription One-time access Individual subscriptions ... Register for E-mail Alerts Advertisement //This is the Right Skyscraper DisplayAds ("Right1,Position2!Right1", "120", "600");
//This is the Left Skyscraper DisplayAds ("Right1,Position2!Position2", "120", "240");
Table of Contents Jump to Section ARTICLES
ARTICLES Penicillamine-induced bullous pemphigoid-like eruption
M. D. Brown; H. V. Dubin
Arch Dermatol.
Linear IgA bullous dermatosis related to lithium carbonate
J. D. McWhirter; K. Hashimoto; S. Fayne; K. Ito
Arch Dermatol.
Positive Nikolsky's and bulla-spread signs in acute bullous lichen planus S. Kaur; M. Singh; B. D. Radotra; S. Sehgal Arch Dermatol. Severe vasculitis during isotretinoin therapy E. H. Epstein Jr; N. S. McNutt; R. Beallo; W. Thyberg; R. Brody; A. Hirsch; J. M. LaBraico

36. Critical Care Medicine - UserLogin
Prazyck T, Fisch A, Simonnet F, et al Lyell s syndrome associated with rifampicintherapy of tuberculosis in an AIDS patient. Scand J Infect Dis 1990;
http://www.ccmjournal.com/pt/re/ccm/fulltext.00003246-200211000-00029.htm
LWWOnline LOGIN eALERTS REGISTER ... Publish Ahead of Print You are attempting to access protected content.
To access this content please login using an established account or create/activate an account.
If you have already created/ activated an online account, please login below: User Name: Password: Note: passwords are CASE SENSITIVE
If you are a new user or guest visiting an LWWonline site for the first time, please complete the new account setup process to view or purchase content.

Subscribe to RSS feed utrdc-pt01
Release 4.0

37. Critical Care Medicine - Abstract: Volume 30(11) November 2002 P 2580-2583 Recur
Recurrent fatal druginduced toxic epidermal necrolysis (Lyell s syndrome) afterputative beta-lactam cross-reactivity Case report and scrutiny of
http://www.ccmjournal.com/pt/re/ccm/abstract.00003246-200211000-00029.htm
LWWOnline LOGIN eALERTS REGISTER ... Publish Ahead of Print Recurrent fatal drug-induced toxic... ARTICLE LINKS:
Fulltext
PDF (180 K) Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative [beta]-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability.
Critical Care Medicine. 30(11):2580-2583, November 2002.
Paquet, Philippe MD, PhD; Jacob, Eric MD; Damas, Pierre MD, PhD; Pierard, Gerald E. MD, PhD Abstract:
Objective: A series of antibiotics may be responsible for toxic epidermal necrolysis. We report two successive episodes of toxic epidermal necrolysis in the same patient. Drug imputability criteria designate a cross-reactivity between two antibiotics of different chemical classes but sharing the [beta]-lactam ring in common. Design: Descriptive case report and review of the literature. Setting: Medical intensive care unit in a university medical center. Patient and Main Results: A 75-yr-old woman developed a first episode of toxic epidermal necrolysis (involving 40% of the body surface) after intake of cefotaxime, a third-generation cephalosporin. Perfusions of high-dose immunoglobulins rapidly improved the lesions, followed by partial reepithelialization in 5 days. Sepsis required the administration of meropenem, which is a carbapenem antibiotic. The epidermal destruction immediately recurred, with extension to previously uninvolved skin areas and fatal consequences. Conclusions: The [beta]-lactam ring present in cephalosporins and carbapenems represents the putative chemical structure responsible for the presently reported cross-reactivity to two antibiotics of different classes. Drugs having any chemical similarity to the initial culprit compound should be strictly avoided when possible in the management of toxic epidermal necrolysis.

38. EVIDENCE THAT NITRIC OXIDE IS AN UPSTREAM MEDIATOR OF FASL-MEDIATED KERATINOCYTE
Summary Toxic epidermal necrolysis (TEN or Lyell s syndrome) is a severe adversedrug reaction that results in extensive necrolysis of the skin due to
http://www.mattek.com/pages/abstracts/297
NEW! EVIDENCE THAT NITRIC OXIDE IS AN UPSTREAM MEDIATOR OF FASL-MEDIATED KERATINOCYTE APOPTOSIS IN TOXIC EPIDERMAL NECROLYSIS. Viard-Leveugle, I., Saurat, J-H., French, L.E. Dermatology, Geneva University Hospital, Geneva , CH. J. Invest. Dermatol. , (1), Abstract #743, (2003).
Keywords: Caspase-8 inhibitor, Cell surface FasL, Cytotoxic, EpiDerm, Fas-FasL mediated keratinocyte apoptosis, FasL, FasL mRNA, Histopathological modification, INOS, Inducible nitric oxide synthase (iNOS), Keratinocyte FasL expression, Keratinocyte apoptosis, Lyell's syndrome, Lytically active, Nitric oxide (NO), Proinflammatory, TEN, Toxic epidermal necrolysis, Z-IETD-FMK, ZVAD
Summary: EpiDerm™, MatTek Corp. ), NOC18 induced keratinocyte FasL expression, keratinocyte apoptosis and histopathological modifications reminiscent of those observed in early biopsy specimens of TEN. In this model, keratinocyte apoptosis could be virtually completely inhibited by the caspase-8 inhibitor Z-IETD-FMK. Taken together, our data show that iNOS via the action of NO is likely to be an upstream trigger of FasL-mediated keratinocyte apoptosis in TEN.
EpiDerm Data Sheet

EpiDerm Specifications

EpiDerm Technical References

Site Map
... Technical References - All Products

39. Tegretol Side Effects, And Drug Interactions - Carbamazepine - RxList Monographs
necrolysis (Lyell s syndrome) (see WARNINGS), StevensJohnson syndrome (see Isolated cases of lupus erythematosus-like syndrome have been reported.
http://www.rxlist.com/cgi/generic/carbam_ad.htm
document.writeln(''); document.writeln(''); Carbamazepine
document.writeln('');
document.writeln(''); Company Issues Pacemaker Malfunction Warning Deaths Seen With Fentanyl Narcotic Pain Patch FDA Reviews Adult Antidepressant-Suicide Link
SIDE EFFECTS
If adverse reactions are of such severity that the drug must be discontinued, the physician must be aware that abrupt discontinuation of any anticonvulsant drug in a responsive epileptic patient may lead to seizures or even status epilepticus with its life-threatening hazards. The most severe adverse reactions have been observed in the hemopoietic system (see BOXED WARNING ), the skin, liver and the cardiovascular system. The most frequently observed adverse reactions, particularly during the initial phases of therapy, are dizziness, drowsiness, unsteadiness, nausea, and vomiting. To minimize the possibility of such reactions, therapy should be initiated at the low dosage recommended.

40. Tegretol Warnings, Precautions, Pregnancy, Nursing, Abuse - Carbamazepine - RxLi
Severe dermatologic reactions including toxic epidermal necrolysis (Lyell ssyndrome) and StevensJohnson syndrome, have been reported with carbamazepine.
http://www.rxlist.com/cgi/generic/carbam_wcp.htm
document.writeln(''); document.writeln(''); Carbamazepine
document.writeln('');
document.writeln(''); Company Issues Pacemaker Malfunction Warning Deaths Seen With Fentanyl Narcotic Pain Patch FDA Reviews Adult Antidepressant-Suicide Link
APLASTIC ANEMIA AND AGRANULOCYTOSIS HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF CARBAMAZEPINE. DATA FROM A POPULATION-BASED CASE CONTROL STUDY DEMONSTRATE THAT THE RISK OF DEVELOPING THESE REACTIONS IS 5-8 TIMES GREATER THAT IN THE GENERAL POPULATION. HOWEVER, THE OVERALL RISK OF THESE REACTIONS IN THE UNTREATED GENERAL POPULATION IS LOW, APPROXIMATELY SIX PATIENTS PER ONE MILLION POPULATION PER YEAR FOR AGRANULOCYTOSIS AND TWO PATIENTS PER ONE MILLION POPULATION PER YEAR FOR APLASTIC ANEMIA. ALTHOUGH REPORTS OF TRANSIENT OR PERSISTENT DECREASED PLATELET OR WHITE BLOOD CELL COUNTS ARE NOT UNCOMMON IN ASSOCIATION WITH THE USE OF TEGRETOL, DATA ARE NOT AVAILABLE TO ESTIMATE ACCURATELY THEIR INCIDENCE OR OUTCOME. HOWEVER, THE VAST MAJORITY OF THE CASES OF LEUKOPENIA HAVE NOT PROGRESSED TO THE MORE SERIOUS CONDITIONS OF APLASTIC ANEMIA

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Page 2     21-40 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20

free hit counter